{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:25:14Z","timestamp":1790616314989,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2002,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>CD70 (CD27 ligand) has been implicated in proapoptotic signals mediated by its receptor CD27 in lymphocytes as well as in proliferative effects induced by reverse signaling in CD70\u2010positive hematopoetic tumor cells. We were able to show that CD70 is expressed at the mRNA and protein level in human meningioma cells, glioma cells from solid human gliomas as well as glioma cell lines and 1 ependynoma. The intensity of CD70 expression varies considerably between different samples from 1 tumor type. In the U343 glioma cell line, CD70 was preferentially localized in the cell processes. Thus, our studies identify CD70 as a new marker molecule in brain tumors that are of nonhematopoetic origin. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.10207","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T23:09:26Z","timestamp":1030316966000},"page":"352-356","source":"Crossref","is-referenced-by-count":56,"title":["CD70\/CD27 ligand, a member of the TNF family, is expressed in human brain tumors"],"prefix":"10.1002","volume":"98","author":[{"given":"Janka","family":"Held\u2010Feindt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Mentlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530120501"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02592977"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.4049\/jimmunol.152.4.1756","article-title":"The cloning of CD70 and its identification as the ligand for CD27","volume":"152","author":"Bowman MR","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90133-B"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.1996.tb00017.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.154.8.3627","article-title":"Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27\/CD70","volume":"154","author":"Agematsu K","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.d01-942.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3556.bloodjournal85123556"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(95)00016-8"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.9.3165"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230427"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(91)90175-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6346"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.4049\/jimmunol.149.10.3208","article-title":"CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions","volume":"149","author":"Sugita K","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3153134.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3378.bloodjournal85123378"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90372-7"},{"key":"e_1_2_6_19_2","first-page":"163","article-title":"Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells","volume":"5","author":"Couderc B","year":"1998","journal-title":"Cancer Gene Ther"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.65051997.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90077-9"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1995.1138"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01573.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.152.4.1762","article-title":"Characterization of the human CD27 ligand, a novel member of the TNF gene family","volume":"152","author":"Hintzen RQ","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90075-2"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018094"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199805000-00009"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.4049\/jimmunol.163.10.5358","article-title":"Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells","volume":"163","author":"Kashii Y","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.2231"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90464-2"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.10207","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.10207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T22:39:15Z","timestamp":1697582355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.10207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3,20]]}},"alternative-id":["10.1002\/ijc.10207"],"URL":"https:\/\/doi.org\/10.1002\/ijc.10207","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,4]]}}}